MELAS phenotype associated with m.3302A>G mutation in mitochondrial tRNALeu(UUR) gene


      The m.3302A>G mutation in the mitochondrial tRNALeu(UUR) gene has been identified in only 12 patients from 6 families, all manifesting adult-onset slowly progressive myopathy with minor central nervous system involvement. An 11-year-old boy presented with progressive proximal-dominant muscle weakness from age 7 years. At age 10, he developed recurrent stroke-like episodes. Mitochondrial myopathy, encephalopathy, lactic acidosis, plus stroke-like episodes (MELAS) was diagnosed by clinical symptoms and muscle biopsy findings. Mitochondrial gene analysis revealed a heteroplasmic m.3302A>G mutation. Histological examination showed strongly SDH reactive blood vessels (SSVs), not present in previous cases with myopathies due to the m.3302A>G mutation. These findings broaden the phenotypic spectrum of this mutation.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Brain and Development
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Bindoff L.A.
        • Howell N.
        • Poulton J.
        • McCullough D.A.
        • Morten K.J.
        • Lightowlers R.N.
        • et al.
        Abnormal RNA processing associated with a novel tRNA mutation in mitochondrial DNA. A potential disease mechanism.
        J Biol Chem. 1993; 268: 19559-19564
        • van den Bosch B.J.
        • de Coo I.F.
        • Hendrickx A.T.
        • Busch H.F.
        • de Jong G.
        • Scholte H.R.
        • et al.
        Increased risk for cardiorespiratory failure associated with the A3302G mutation in the mitochondrial DNA encoded tRNALeu(UUR) gene.
        Neuromuscul Disord. 2004; 14: 683-688
        • Hutchison W.M.
        • Thyagarajan D.
        • Poulton J.
        • Marchington D.R.
        • Kirby D.M.
        • Manji S.S.
        • et al.
        Clinical and molecular features of encephalomyopathy due to the A3302G mutation in the mitochondrial tRNALeu(UUR) gene.
        Arch Neurol. 2005; 62: 1920-1923
      1. Ballhausen D, Guerry F, Hahn D, Schaller A, Nuoffer JM, Bonafé L, et al. Mitochondrial tRNALeu(UUR) mutation m.3302A>G presenting as childhood-onset severe myopathy: threshold determination through segregation study. J Inherit Metab Dis, in press. doi:10.1007/s10545-010-9098-2.

        • Schaefer A.M.
        • McFarland R.
        • Blakcly E.I.
        • He L.
        • Whittaker R.G.
        • Taylor R.W.
        • et al.
        Prevalence of mitochondrial DNA disease in adults.
        Ann Neurol. 2008; 63: 35-39
        • Trounce L.A.
        • Kim Y.L.
        • Jun A.S.
        • Wallace D.C.
        Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines.
        in: Methods in enzymology. vol. 264. Academic Press, San Diego, USA1996: 484-509
        • Akanuma J.
        • Muraki K.
        • Komaki H.
        • Nonaka I.
        • Goto Y.
        Two pathogenic point mutations exist in the authentic mitochondrial genome, not in the nuclear pseudogene.
        J Hum Genet. 2000; 45: 337-341
        • Betts J.
        • Jaros E.
        • Perry R.H.
        • Schaefer A.M.
        • Taylor R.W.
        • Abdel-All Z.
        • et al.
        Molecular neuropathology of MELAS: level of heteroplasmy in individual neurons and evidence of extensive vascular involvement.
        Neuropathol Appl Neurobiol. 2006; 32: 359-373
        • Hasegawa H.
        • Matusoka T.
        • Goto Y.
        • Nonaka I.
        Strongly succinate dehydrogenase-reactive blood vessels in muscles from patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
        Ann Neurol. 1991; 29: 601-605
        • Goto Y.
        Clinical features of MELAS and mitochondrial DNA mutations.
        Muscle Nerve. 1995; 3: S107-S112